RecruitingNCT06635590

Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes

The Impact of Hyperkalemia-Induced ECG and ECHO Findings on Early and Late Mortality in Patients With Chronic Kidney Disease


Sponsor

Saglik Bilimleri Universitesi

Enrollment

40 participants

Start Date

Feb 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Patients with CKD ( eGFR \< \<60 mL/min/1,73 m2) presenting to emergency department with isolated hyperkalemia will be study population. Pre and post treatment ECG and echocardiographic findings will be recorded. Investigator will not intervene with the treatment decision of responsible physician and will not delay any intervetion or treatment for the sake of study. Data will be compared in terms of ECHO and ECG findings depending on hyperkalemia level and response to treatment.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patients over 18 years old
  • Chronic kidney disease patients with eGFR \< 60 mL/min/1.73 m²
  • Patients with hyperkalemia detected in the emergency department
  • Patients willing to participate in the study and who sign the consent form

Exclusion Criteria5

  • Patients under 18 years old
  • Patients who do not wish to participate in the study
  • Patients without chronic kidney damage
  • Patients without detected hyperkalemia
  • Patients needing cardiopulmonary resuscitation due to hyperkalemia

Locations(1)

Etlik City Hospital

Ankara, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06635590


Related Trials